On the other hand, the CRCs of hormone receptor (HR)+/HER2- tumors, presented lower number of CNAs and less complexes array-CGH profiles (except case 2), compatible to what is reported in the intrinsic molecular luminal A breast cancer subtype [20–23]. This evidence concerns the gene ERBB2 and breast carcinoma.